Using the evidence-based deprescribing guideline method established through the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, Dr. Reeve developed an Australian/Canadian focused prescribing guideline for acetylcholinesterase inhibitors and memantine. Next steps include an evaluation of the guideline impact in the Australian context.
Lead: Dr. Emily Reeve
Co-investigators: Dr. Barbara Farrell,
Contact: [email protected]
Funder (2016-2020): National Health and Medical Research Council – Australian Research Council Dementia Research Fellowship
Publications:
Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P, Chenoweth L, Gorman M, Quirke L, Bethune G, Forbes F, Hilmer S. Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine. Sydney: University of Sydney. 2018. Available at: http://sydney.edu.au/medicine/cdpc/resources/deprescribing-guidelines.php
